Introduction
Multiple myeloma (MM) is characterized by a clonal proliferation of neoplastic plasma cells in the bone marrow and is the second most common hematological malignancy [1, 2] . At present, a cure for multiple myeloma has not been achieved with chemotherapeutic regimen, and many patients die of drug-resistant diseases. High-dose chemotherapy with stem cell support has achieved higher response rates than conventional therapy, but few patients remain in long-term remission [3] . Thus, the development of new effective anticancer targets to treat both early and advanced MM seems to be an attractive perspective.
Prostaglandins are important mediators implicated in inflammation and angiogenesis, and support the growth of several solid tumors [4, 5] . Cyclooxygenase 2 (COX-2) is the key enzyme of prostaglandin synthesis in inflamed tissues [6] . In most normal tissues, its expression is at a low level, but is induced by cytokines and growth factors [7] . Overexpression of COX-2 is related to tumorigenesis by mechanisms of chronic inflammation, immunosuppression, apoptosis resistance, and angiogenesis [8] . Overexpression of COX-2 has been reported in various cancers such as breast, stomach, colon, and lung [5, 9] . MM is known to involve a deregulated cytokine network with the secretion of inflammatory mediators [10] , and it has been recently reported that COX-2 is frequently expressed in MM [11, 12] . In the present study, we investigated the function of COX-2 by siRNA-mediated gene silencing in human myeloma RPMI8226 cells. Silencing of COX-2 leads to an inhibited cell proliferation and induced apoptosis, which is independent of the Bcl-2 family.
Materials and methods
siRNA for COX-2 RNA interference mediated by duplexes of 21-nucleotide RNA was performed in RPMI8226 cells. The siRNA sequence was used to target exon 5 of the COX-2 gene (GenBank accession No NM_000963). The 21 nucleotide RNA for silencing were chemically synthesized by Ambion RNA Co (Austin, TX, USA). COX-2 siRNA sequences were as follows: sense, 5'-GCACUUCACGCAUCAGUUUtt-3' and antisense, 5'-AAACUGAUGCGUGAAGUGCtg-3'.
Cell culture and transfection of siRNA The RPMI8226 human myeloma cell line and one colorectal cell line (HT-29) were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in RPMI1640 containing 10% fetal bovine serum (Gibco, Grand Island, NY, USA), 100 units/mL penicillin, and 100 µg/mL streptomycin at 37 o C with 5% CO 2 . The cells were passaged 2-3d before nucleofection, and the cells for nucleofection were in their logarithmic growth phase.
The transfection of siRNA used the Amaxa cell optimization kit V (Amaxa, Koeln, Germany) and followed the Amaxa guidelines. Briefly, the cells were resuspended in the nucleofector V solution. 100 µL of cell suspension at a density of 2×10 6 -5×10 6 /mL mixed with 2 µg of pmax green fluorescent protein (GFP) vector plus 1 µL of 100 µmol/L siRNA were transferred to a cuvette and nucleofected with an Amaxa nucleofector apparatus. The cells (RPMI8226 siRNA ) were transfected using the G-16 pulsing parameter and were immediately transferred into wells containing 37 o C pre-warmed culture medium in 12-well plates. Untreated cells (RPMI8226 Untreated ) and cells (RPMI8226 Blank ) in nucleofector solution, without siRNA and with the application of the electroporation program, were both used as negative controls. Twenty four hours after the electroporation, the cells were monitored with an Olympus BH-2 fluorescence microscope (Tokyo, Japan).
RT-PCR analysis Total RNA was isolated from the RPMI8226 cells using TRIzol Reagent (Gibco-BRL, Gaithersburg, MD, USA). 4 µg RNA was reverse transcribed to cDNA by the Thermoscript RT-PCR System reagent (Gibco-BRL, USA). Primers for PCR reaction were designed specially to human COX-2 gene. The sequences was 5'-CCGA-GGTGTATGTATGAGTG-3' for the sense and 3'-GGAAGA-GATTGTAGAGAGGA-5' for the antisense. Primers for control were designed according to the GAPDH gene. The sequences were as follows: 5'-GTCATCATCTCTGCCCCCTC-TGCT-3' for the sense and 3'-GACGCCTGCTTCACCACCT-TCTTG- 5 (20 µg) were boiled in Laemmli sample buffers and fractionated on 10% SDS-PAGE. The separated proteins in the gel were transferred onto polyvinylidine difluoride (PVDF) membranes using an electroblot apparatus (Bio-Rad Inc, Hercules, CA, USA). The filters were blocked for 2 h in PBS containing 0.1% Tween 20 and 5% low fat milk, and the filters were then incubated with specific primary Abs (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at dilution of 1:200 in TBS/T, 5% low fat milk at 4 o C for 12 h. The membranes were then washed with PBS-T and incubated with horseradish peroxidase (HRP) conjugated anti-goat Abs or anti-rabbit Abs (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at dilution of 1:1000 in TBS/T, 5% low fat milk for in room temperature for 1 h. Specific signals were detected on X-ray films using an enhanced chemiluminescence detection system (SuperSignal, Pierce, Rockford, IL, USA). The blots were then stripped and reblotted with the antibody against β-actin to ensure that equivalent levels of proteins were present in each lane.
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) assay RPMI8226
siRNA , RPMI8226 Untreated , or RPMI8226 Blank cells were seeded onto 96-well plates at a density of 5×10 4 /mL after being treated or untreated (200 µL/ well) and cultured for 12, 24, 48, and 72 h, respectively. Subsequently, 20 µL MTT (Janssen Chimica Co, New Brunswick, NJ, USA) at a concentration of 5 g/L was added to each well, and the cells were incubated for an additional 4 h at 37 o C. After a brief centrifugation, supernatants were carefully removed and 200 µL DMSO was added to the cells. After the insoluble crystals were completely dissolved, absorbance at 490 nm was measured using an EL×800 reader (Bio-Tek Instruments, Winooski, VT, USA).
Annexin-V staining Annexin-V staining was performed based on the Annexin-V-fluorescein isothiocyanate (FITC) apoptosis assay kit (Bender MedSystems, Vienna, Austria). In this assay, Annexin-V-FITC (1:250) and propidium iodide (PI, 1 µg/mL) were used. FITC can specifically bind to the phosphatidyl serine (PS) residues on the cell membrane, while PI can bind to DNA once the cell membrane has become permeable. The cells were stained and analyzed by FACScan (Becton Dickinson, Franklin Lakes, NJ, USA). The data were analyzed using the CellQuest (Becton Dickinson, USA) software. For each analysis, 10 000 events were recorded.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining Silencing of COX-2 induced apoptosis was also confirmed by TUNEL by TACS (Total Access Cellular System) TdT Kit (R&D Systems, Inc, Minneapolis, MN, USA). Briefly, the slides were rinsed with Ca 2+ , Mg
2+
, and DNase-free PBS (10 mmol/L PBS, pH7.4) and permeabilized with proteinase K at room temperature to make the DNA accessible to the labeling enzyme. For the positive control, the cells were incubated with TACS nuclease for 30 min, which generated DNA strand breaks in virtually every cell. Endogenous peroxidase activity was quenched using 5% H 2 O 2 (in methanol, v/v) for 5 min, and the cells were incubated with TdT labeling buffer for 5 min before starting the labeling reaction. Then the cells were incubated with the TdT enzyme and biotinylated nucleotides (for negative control, labeling buffer was used instead of TdT enzyme) for 1 h at 37 o C in a humidified chamber. The reaction was stopped by adding TdT stop buffer for 5 min. The slides were incubated with streptavidin-conjugated horseradish peroxidase for 10 min. A brown color was developed with incubation in the diaminobenzidine (DAB) solution (Sigma, St Louis, MO, USA) for 7 min at room temperature. The slides were counterstained in 1% methyl green for 1.5 min and visualized and scored under a light microscope. The apoptosis was evaluated by calculating the rate of positive cells (brown-stained cells) at 10 arbitrarily-selected fields at a magnification of 400 in a double-blinded manner.
Statistical analysis Statistical analysis was performed using the F and q tests by SPSS10.0 (SPSS Inc, Chicago, IL, USA), and statistical significance was defined as P<0.05. Data were expressed as mean± SD for at least 3 experiments.
Results
Silencing COX-2 gene with siRNA duplexes To estimate transfection efficacy, 2 µg pmaxGFP vector was cotransfected into RPMI8226 cells with a siRNA duplex designed against maxGFP. More than 300 cells were detected for fluorescence (Figure 1 ). The same system was used as for the silencing of the COX-2 gene. RT-PCR (Figure 2 ) and Western blot (Figure 3) analysis indicated that the transcription and expression of the COX-2 gene was extremely attenuated in the cells transfected with the specific COX-2 siRNA. Thus, we demonstrated that COX-2 specific siRNA can efficiently suppress COX-2 expression.
siRNA mediated silencing of COX-2 inhibits proliferation of RPMI8226 cells As shown in Figure 4 , silencing of COX-2 led to the inhibition of cell proliferation in RPMI8226 cells. Blank cells were stained with Annexin-V to investigate whether apoptosis would occur. The silencing of COX-2 via siRNA led to sig- 6 ). Meanwhile, TUNEL assay was used to confirm whether apoptosis was elevated and draw the same result. This demonstrated that the silencing of COX-2 via siRNA brought obvious apoptosis to the RPMI8226 siRNA cells. Silencing the COX-2 gene has no effect on the expression of Bcl-2 family proteins in RPMI8226 cells We examined the expression of Bcl-2 family proteins, Bcl-2 and Bax, which play vital roles in programmed death in various types of cells. As shown in Figure 7 , the result of the Western blot analysis showed that no significant differences could be found in the expression of both the Bcl-2 and Bax proteins in RPMI8226 siRNA cells compared with the RPMI8226 Untreated or RPMI8226 Blank cells, which demonstrated that silencing the COX-2 gene inhibited proliferation and induced apoptosis in RPMI8226 cells via a Bcl-2 independent way.
Discussion
The nucleofector technique is a new non-viral transfection method especially designed for hard-to-transfect cell lines [13] . COX-2 gene silencing has been reported in various tumor cells [14] [15] [16] , which suggests that siRNA is an effective technique for tumor study and treatment. However, there have been no reports of silencing COX-2 in myeloma cells until recently. Here, we successfully silenced the COX-2 gene in human RPMI8226 myeloma cells by RNA interfering. For this study, 3 different pairs of siRNA fragments were provided and the most effective one was chosen for this study. Co-transfection of pmaxGFP, which encodes the GFP from copepod Pontellina p. with an siRNA directed against maxGFP into RPMI8226 cells helps us to understand the transfection efficiency. Successful gene silencing is monitored as a decrease of green fluorescence compared to the control sample using fluorescence microscopy.
COX and lipoxygenase (LOX) are 2 important enzyme classes that metabolize polyunsaturated fatty acids and affect carcinogenesis [17, 18] . We have previously shown that 12-LOX, an important arachidonic acid-metabolizing enzyme, expressed in RPMI8226 cells and its specific inhibitor, baicalein, plays an important role in the growth and apoptosis of RPMI8226 cells [19] . COX-2 is essential for the survival and proliferation of malignant cells [5] . Recently, COX-2 has been reported to be frequently expressed in MM and is an independent predictor of poor outcome [11] . However, the function of COX-2 in the development of human MM remains less clear even though its inhibitor celecoxib has been involved in clinical trials combined with thalidomide for refractory and relapsed myeloma therapy [20] . In this study, we demonstrate that successfully silencing the COX-2 gene using siRNA duplexes can lead to the inhibition of COX-2 expression in transfected RPMI8226 cells. Furthermore, significant growth inhibition and apoptosis induction have been detected in these transfected cells (Figures 4-6 ). Interleukin-6, a pleiotropic cytokine known to play a critical role in the survival and growth of multiple myeloma cells [6] , participates in a cytokine network and can be induced by prostaglandin E2 (PGE2), a major product of COX-2 [21] . Therefore, COX-2 seems to play an important role in MM via the cytokine network [22] . However, the direct effects of COX-2 on MM cells have not been elucidated [23] . There are 2 main apoptosis signaling pathways: death receptor-dependent apoptosis and mitochondria-dependent apoptosis [24] . As anti-apoptosis proteins, Bcl-2 and Bax have been demonstrated to prevent the release of cytochrome C into the cytosol and inhibit the subsequent activation of caspase 9 [25] . The mitochondrial-mediated pathway of apoptosis is regulated by the Bcl-2 family of anti-apoptotic (Bcl-2, Bcl-x L , and Mcl-1) and pro-apoptotic proteins (Bax, Bad, and Bak), and Bcl-2 inhibits apoptosis by interacting and forming inactivating heterodimers with Bax/Bak [26] . PGE2 had been found to inhibit apoptosis via a Bcl-2-dependent pathway in a human colonic cancer cell line [27] . It was found that some antimultiple myeloma agents, such as dexamethasone, thalidomide, and proteasome inhibitors (PS-341), induce apoptosis in myeloma cell lines or patient cells asso- ciated with the downregulation of Bcl-2 or/and upregulation of Bax [3] ; however, in this study, we found that although COX-2 was knocked down in RPMI8226 cells and obvious apoptosis was observed, the expression of Bcl-2 and Bax did not decrease. This demonstrates that apoptosis in RPMI8226 cells, induced by the silencing of COX-2, is independent of modulation of Bcl-2 and Bax, which is consistent with the results of Zhang's report [23] . In summary, our study suggests that COX-2 takes considerable part in the regulation of cellular proliferation and apoptosis of human myeloma cells, which is independent of the Bcl-2 pathway. COX-2 could be an important target for MM treatment, and small interfering RNA of COX-2 could serve as an effective tool.
